ProCE Banner Activity

Incorporating TROP-2–Targeted Therapies Into the Breast Cancer Landscape


Download these slides from a live symposium at ASCO 2023 to learn more about TROP-2 targeted therapies for patients with breast cancer.

Released: June 02, 2023



Aditya Bardia

Aditya Bardia, MD, MPH, FASCO

Professor of Medicine
Geffen School of Medicine at UCLA
Director, Breast Oncology Program
Assistant Chief (Translational Research)
Division of Medical Oncology
Director of Translational Research Integration
UCLA Health Jonsson Comprehensive Cancer Center
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc.


Daiichi Sankyo

Gilead Sciences, Inc.